Enochian Biosciences Statistics Share Statistics Enochian Biosciences has 63.7M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 63.7M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 27.81M Failed to Deliver (FTD) Shares 18,870 FTD / Avg. Volume 7.41%
Short Selling Information The latest short interest is 801.36K, so 0% of the outstanding
shares have been sold short.
Short Interest 801.36K Short % of Shares Out n/a Short % of Float 3.02% Short Ratio (days to cover) 6.65
Valuation Ratios The PE ratio is -1.86 and the forward
PE ratio is null.
Enochian Biosciences's PEG ratio is
-0.1.
PE Ratio -1.86 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.14 P/FCF Ratio -13.6 PEG Ratio -0.1
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Enochian Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.07,
with a Debt / Equity ratio of 0.03.
Current Ratio 0.07 Quick Ratio 0.07 Debt / Equity 0.03 Debt / EBITDA -0.05 Debt / FCF -0.34 Interest Coverage -80.73
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.67M Employee Count 22 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -72.69% in the
last 52 weeks. The beta is 0.94, so Enochian Biosciences's
price volatility has been higher than the market average.
Beta 0.94 52-Week Price Change -72.69% 50-Day Moving Average 0.97 200-Day Moving Average 1.11 Relative Strength Index (RSI) 77.82 Average Volume (20 Days) 254,603
Income Statement
Revenue n/a Gross Profit -121.86K Operating Income -81.64M Net Income -80.65M EBITDA -81.52M EBIT -79.64M Earnings Per Share (EPS) -0.84
Full Income Statement Balance Sheet The company has 220.47K in cash and 3.79M in
debt, giving a net cash position of -3.57M.
Cash & Cash Equivalents 220.47K Total Debt 3.79M Net Cash -3.57M Retained Earnings -332.46M Total Assets 117.73M Working Capital -25.17M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.97M
and capital expenditures -70.43K, giving a free cash flow of -11.04M.
Operating Cash Flow -10.97M Capital Expenditures -70.43K Free Cash Flow -11.04M FCF Per Share -0.11
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
